CT Portography in Grading of Liver Cirrhosis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-25

Study Completion Date

2019-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Esophageal variceal bleeding and hepatic encephalopathy are serious complications of hepatic cirrhosis, and they may lead to high mortality rate and severely threaten life quality of the patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hemodynamic Alterations in Liver Cirrhosis Validated by Non-invasive MR Compared to Invasive Assessment

NCT03443934

Portal Hypertension Liver Diseases Liver Cirrhoses +1 more

COMPLETED

Effect of Variceal Eradication on Portal Circulation

NCT04538209

Portosystemic Collateral Veins

UNKNOWN

Risk Factors and Outcomes of Acute Venous Thromboembolism in Cirrhotic

NCT03580577

Liver Cirrhosis Venous Thromboembolism

UNKNOWN

MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis

NCT03438916

Portal Hypertension Cirrhosis Esophageal Varices +4 more

COMPLETED

Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound

NCT07051369

Cirrhosis, Liver

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The occurrence and development of Esophageal variceal bleeding and hepatic encephalopathy are closely related with portal vein system diseases, such as collateral circulation of portal hypertension and portal vein thrombosis.

The prevention of Esophageal variceal bleeding and hepatic encephalopathy in hepatic cirrhosis has become a hot spot in clinical practice.

Three-dimensional reconstruction of images obtained by multi-slice spiral computed tomography portography (MSCTP) is clear, realistic, and accurate.

It can directly and quickly display all anatomical information of collateral portal vein system, and is recognized as a good method to display blood vessels

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CT Portography Grading of Liver Cirrhosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

multislice computed tomography portography

imaging modality

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with cirrhosis and\\or portal hypertension diagnosed by; laboratory or radiological parameters.

Exclusion Criteria

* Patients with ligation, disconnection or shunting of esophageal varices. Patients with combined hepatic malignant tumor Patients with splenectomy. Patients with renal dysfunction or iodine allergy.

Eligible Sex

ALL

Accepts Healthy Volunteers

No